Skip to main content

Table 1 Basic and clinical data of RIPC and control patients

From: Activities of cardiac tissue matrix metalloproteinases 2 and 9 are reduced by remote ischemic preconditioning in cardiosurgical patients with cardiopulmonary bypass

Variable Control (N = 17) RIPC (N = 18) P-value
Demographic data    
Male (N) 17 (100%) 14 (77.8%) 0.10
Female (N) 0 (0%) 4 (22.2%) 0.10
Age (years) 63 ± 9 68 ± 11 0.03
Weight (kg) 86 ± 9.5 80 ± 11 0.04
BMI (kg/m2) 28 ± 3.2 26 ± 3.6 0.04
Type of surgery    
CABG (N) 9 (52.9%) 13 (72.2%) 0.31
AVR (N) 2 (11.8%) 2 (11.1%) 1.00
Combi (N) 6 (35.3%) 3 (16.7%) 0.26
Perioperative data    
Bypass time (min) 128 ± 34 108 ± 51 0.01
Aortic clamping time (min) 86 ± 25 70 ± 36 0.01
EuroSCORE 3 ± 2 4 ± 2 0.03
  1. AVR, aortic valve replacement; BMI, body mass index; CABG, coronary artery bypass graft; Combi, combined surgery.